Plasma Cell-Free DNA and Caspase-3 Levels in Patients with Chronic Kidney Disease.
Anna ClementiMaria Grazia PetrisSabrina Milan MananiMassimo De CalGiovanni Giorgio BattagliaClaudio RoncoMonica ZanellaPublished in: Journal of clinical medicine (2023)
Patients with chronic kidney disease show higher levels of cfDNA and caspase-3 levels compared to the control group. Based on these preliminary results, we speculated that the worsening of renal damage and the increase in uremic toxin concentration could be associated with higher levels of cfDNA and caspase-3 levels, thus reflecting the potential role of inflammation and apoptosis in the progression of CKD. Future studies should focus on the validation of these promising preliminary results.